Differential Activation of Smads in HeLa and SiHa Cells That Differ in Their Response to Transforming Growth Factor-β
Open Access
- 1 August 2004
- journal article
- Published by Elsevier BV
- Vol. 279 (35), 36287-36292
- https://doi.org/10.1074/jbc.m404568200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor β-induced Smad signaling in human ovarian cancer cellsBiochemical and Biophysical Research Communications, 2003
- Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancerOncogene, 2003
- Calcium Induces Cell Survival and Proliferation through the Activation of the MAPK Pathway in a Human Hormone-dependent Leukemia Cell Line, TF-1Published by Elsevier BV ,2003
- Aberrant expression of Smad4 results in resistance against the growth‐inhibitory effect of transforming growth factor‐β in the SiHa human cervical carcinoma cell lineInternational Journal of Cancer, 2001
- The TGFβ Receptor Activation Process: An Inhibitor- to Substrate-Binding SwitchMolecular Cell, 2001
- TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activationOncogene, 2000
- Transforming Growth Factor-β1-induced Activation of the ERK Pathway/Activator Protein-1 in Human Lung Fibroblasts Requires the Autocrine Induction of Basic Fibroblast Growth FactorPublished by Elsevier BV ,2000
- Lack of responsiveness to TGF-β1 in a thyroid carcinoma cell line with functional type I and type II TGF-β receptors and Smad proteins, suggests a novel mechanism for TGF-β insensitivity in carcinoma cellsMolecular and Cellular Endocrinology, 1999
- Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasisOncogene, 1999
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences of the United States of America, 1979